Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Sagar Dhamne Image

      Sagar Dhamne, MBBS, MD

      Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

      About Dr. Sagar Dhamne

      I am an Anatomic Pathologist with expertise in Breast diseases and Breast cancer. Within the breast lesions my clinical interests are papillary lesions of the breast, and radiology-pathology correlation, especially focusing how MRI breast findings correlate with histology findings. As a research scientist I am interested in elucidating molecular underpinnings of early stages of breast cancer especially DCIS and application of new emerging technologies like AI to the field of pathology. I frequently collaborate with clinical colleagues in clinical trial protocols focusing in treatment of hormone receptor positive breast carcinomas. I am also involved in the trainee education and serve on intra-departmental educational committees. I am the Chair of the Residents’ and Fellows’ Seminar committee at the Texas Society of Pathologists (TSP) entrusted with encouraging and furthering pathology education in Texas. I strongly advocate for the field of pathology being a Delegate representing the State of Texas in the College of American Pathologists (CAP) House of Delegate.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Adjunct Associate Professor, Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas

      Education & Training

      Degree-Granting Education

      2008Lokmanya Tilak Municipal Medical College, Mumbai, Maharashtra, IN, Pathology, MD
      2004Byramjee Jeejeebhoy Medical College, Pune, Maharashtra, IN, Medicine, MBBS

      Postgraduate Training

      2014-2015Postgraduate Fellow, Breast Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
      2010-2014Resident, Pathology (AP/CP), Baylor College of Medicine, Houston, Texas
      2003-2003Intern, Sassoon General Hospitals, Pune, Maharashtra

      Licenses & Certifications

      2015Texas Medical Board
      2014Michigan State License

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, 2023 - 2024

      Assistant Professor, Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, 2016 - 2023

      Administrative Appointments/Responsibilities

      Director, Department of Pathology and Laboratory Medicine, Ben Taub General Hospital, Houston, Texas, 2023 - 2024

      Director Baylor Citywide Pathology Grand Rounds Committee (AP), Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, 2020 - 2024

      Director of Breast Pathology Trainee Elective Rotation, Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, 2017 - 2024

      Chief Resident in Pathology, Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, 2013 - 2014

      Intramural Institutional Committee Activities

      Member, PRS Clinical Revenue Cycle Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, Clinical Curriculum Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Member, Laboratory Performance Improvement Committee, Ben Taub General Hospital, 2023 - 2024

      Director, Quality Assurance and Performance Improvement, Ben Taub General Hospital, 2023 - 2024

      Member, Clinical Curriculum Committee, Baylor College of Medicine, 2020 - 2024

      Extramural Institutional Committee Activities

      Chair, Residents' and Fellows' Seminar Committee, Texas Society of Pathology, 2022 - Present

      Member, Resident and Fellows Seminar Committee, Texas Society of Pathology, 2019 - 2022

      Editorial Activities

      Member of the editorial board, Annals of Laboratory and Clinical Science, 2016 - Present

      Honors & Awards

      2022O'neal Spjut Award for Leadership and Unselfish Commitment to Department Mission, Department of Pathology & Immunology, Baylor College of Medicine
      2021Norton Rose Fulbright Faculty Excellence Award - Teaching and Evaluation, Baylor College of Medicine
      2021Professional educator Appreciation and Recognition Award (PEAR), Baylor College of Medicine
      2019Faculty Award for Outstanding Resident Teaching - Anatomic Pathology, Department of Pathology & Immunology
      2019Early Career Faculty Award for Excellence in Patient Care, Baylor College of Medicine

      Professional Memberships

      Houston Society of Clinical Pathologists

      2025 - Present

      Houston Society of Clinical Pathologists

      2024 - 2025

      International Society of Breast Pathologists

      2016 - Present

      Association of Clinical Scientists

      2016 - Present

      United States and Canadian Academy of Pathology

      2013 - Present

      College of American Pathologists

      2010 - Present

      Texas Society Of Pathology

      2010 - Present

      American Society of Clinical Pathology

      2010 - 2016

      Selected Presentations & Talks

      Local Presentations

      1. 2025. Interesting case presentation in Breast Pathology. Invited. The William O. Russell Annual Conference, Nuts and Bolts in Surgical Pathology. Houston, Texas, US.
      2. 2025. Papillary lesions of the breast and utility of immunohistochemistry in these lesions. Invited. Breast Pathology Lecture Series. Houston, Texas, US.
      3. 2020. Biomarker analysis in breast cancers: Recent updates. Invited. Citywide Baylor Pathology Grand Rounds. Houston, Texas, US.
      4. 2019. Endocrine therapy in the treatment of ER positive breast cancers. Invited. Trainee Research Symposium. Houston, Texas, US.
      5. 2017. A comparison of Breast Cancers' Radiologic, Macroscopic and Microscopic Imagery. Invited. All-City Anatomic Pathology Symposium. Houston, Texas, US.
      6. 2016. Her2 overexpression in Breast Carcinomas. Invited. Citywide Baylor Pathology Grand Rounds. Houston, Texas, US.

      Regional Presentations

      1. 2022. When to expect the unexpected in Breast Pathology. Invited. 61st HSCP Annual Symposium. Houston, Texas, US.

      National Presentations

      1. 2022. Clinical Practice Updates in Fibroepithelial Lesions of the Breast. Invited. AP/CP Grand Rounds, Department of Pathology and Laboratory Medicine. Madison, Wisconsin, US.

      International Presentations

      1. 2021. Breast Pathology: What the surgeon needs to know. Invited. Virtual, IN.
      2. 2021. Papillary lesions of the breast. Invited. 2021 Annual Conference of the Latin American Society of Pathology (SLAP). Virtual, CR.
      Read More
      Less

      Grant & Contract Support

      Date: 2026 - Present
      Title:ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions (ANGEL)
      Funding Source:ARTIDIS
      Role:Co-PI
      ID:ART-BrC-0102

      Selected Publications

      Peer-Reviewed Articles

      1. Delgado Casanova, LB, Dhamne, S, Resetkova, E, Guirguis, MS, Puvvala, A, Bevers, TB, Bedrosian, I, Huo, L, Wanis, K. Risk of malignancy after diagnosis of radial sclerosing lesion without atypia. Breast Cancer Research and Treatment 217(2), 2026. e-Pub 2026. PMID: 42257745.
      2. Young, A, Bu, W, Jiang, W, Ku, AT, Kapali, J, Dhamne, S, Qin, L, Hilsenbeck, SG, Du, YN, Li, Y. Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer. Cancer Prevention Research 15(1):3-10, 2022. e-Pub 2022. PMID: 34667127.
      3. McLemore LE, Albarracin CT, Dhamne S, Chen H. Her2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines. Breast Cancer Res Treat 187(1):95-104, 2021. e-Pub 2021. PMID: 33813685.
      4. Gadgil NM, Dhamne S. Clinicopathological Study of nephrotic syndrome in Indian children: A tertiary care experience. Annals of Pathol and Lab Med 4(1):A28-38, 2017. e-Pub 2017.
      5. Dhamne S, Soundars E, Zarrin-Khameh N. Pathologic findings in women with atypical glandular cells on Pap test. J Am Soc Cytopathol 5(1):50-55, 2016. e-Pub 2016. PMID: 31042539.
      6. Kander E, Raza S, Dhamne S, Solari M, Jain S. Adenoid cystic carcinoma of the breast from a single-center cohort. Cancer Treat Commun 4:182-187, 2015. e-Pub 2015.
      7. Phalak K, Sedgwick EL, Dhamne S, Gutierrez C. AIRP best cases in radiologic-pathologic correlation: malignant phyllodes tumor with osteosarcomatous differentiation. Radiographics 33(5):1377-81, 2013. e-Pub 2013. PMID: 24025930.
      8. Dhamne S, Brown RE, Covinsky M, Dhamne CA, Tatevian N. Clear cell sarcoma of kidney: morphoproteomic analysis reveals genomic correlates and therapeutic options. Pediatr Dev Pathol 16(1):20-27, 2013. e-Pub 2013. PMID: 22256788.
      9. Schechet SA, Askenasy EP, Dhamne S, Scott BG. Anemia and jejunal intussusception: An unusual presentation for a metastatic phyllodes breast tumor. Int J Surg Case Rep 3(2):62-64, 2012. e-Pub 2012. PMID: 22288047.
      10. Dhamne S, Gadgil NM, Padmanabhan A. Leiomyosarcoma of the renal pelvis. Indian J of Pathol Microbiol 52(4):549-51, 2009. e-Pub 2009. PMID: 19805970.
      11. Savitri Krishnamurthy, Dhamne S. A multi-reader study of pathology trainees and faculty comparing the performance of whole slide digital images with light microscopy for frozen section analysis. USCAP.

      Invited Articles

      1. Dhamne S, Albarracin CT. Ki67 as a Biomarker of Prognosis and Prediction: Is it Ready for Use in Routine Pathology Practice?. Curr Breast Cancer Rep 6(4):260-266, 2014. e-Pub 2014.
      2. Dhamne S, Albarracin CT. Evolving Role of Ki67 as a Predictive and Prognostic Marker in Breast Cancer. J Clin Exp Pathol 4(5):e117, 2014. e-Pub 2014.

      Review Articles

      1. Sellers, CM, Ortiz-Perez, T, Dhamne, S, Roark, A, Gilman, L. Intramammary Metastases from Extramammary Malignancies. Current Breast Cancer Reports 15(2):85-96, 2023. e-Pub 2023.
      2. Villanueva H, Dhamne S, Edwards D. The emerging role of steroid hormone receptors in Ductal carcinoma in situ of the breast. J Mammary Gland Biol Neoplasia 23(4):237-248, 2018. e-Pub 2018. PMID: 30338425.

      Abstracts

      1. Dhamne S, Nangia J, Osborne CK, Schiff R, Rimawi M. Biomarkers of response to neoadjuvant endocrine therapy with Anastrozole alone or in combination with fulvestrant in ER-positive Her 2 negative breast cancers (PACT-01 trial).
      2. McLemore LE, Dhamne S, Albarracin CT. Her 2 testing in breast cancers: Comparison of Assays and Interpretation Using ASCO-CAP 2013 and 2018 guidelines. USCAP annual meeting.
      3. Dhamne S, Albarracin CT. Estrogen receptor immunohistochemical staining versus Oncotype Dx: Clinicopathologic characteristics and recurrence scores of concordant and discordant cases. USCAP annual meeting.
      4. Goetz L, Powell J, McGowan L, Dhamne S. Changing Clinicopathologic features of malignant phyllodes tumors in the setting of COVID-19 pandemic: Size Matters. USCAP Annual Meeting.
      5. Taha h, Shitawi M, Dhamne S. Encapsulated papillary carcinoma in male breast: a rare case. Texas Society of Pathology Annual Meeting.
      6. Platero-Portillo t, Taha, H, Shitawi M, Dhamne S. The role of MRI-guided Biopsy in Breast cancer diagnosis and patient monitoring - A single institution analysis. USCAP Annual Meeting 2024.
      7. Wang JC, Dhamne S, Shitawi M, Taha H, Zhang S. Phyllodes Tumor of The Breast in Hispanic Population: A Clinicopathological Study of 226 Cases. USCAP Annual Meeting 2025.
      8. Alrohaibani A, Dhamne S, Albarracin CT, Arun B, Chen H. ESR1 Mutated Advanced Breast Cancer: Clinicopathological and Molecular Characteristics. USCAP Annual Meeting 2025.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top